Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study

Table 2 Transfusion financial summary

Indicators	Control	EACA	TXA
Perioperative transfusion rate	36.5% (38/104)	20.6% (20/97)^*	10.6% (10/94)^†,§
Mean perioperative transfusion no. of units	1.13	0.62^*	0.21^†,§
Mean cost of blood transfusion per patient (RMB)	900.00	498.97^*	170.21^†,§
Mean cost saving for transfusions (RMB) compared with control	-	408.00	736.00
Generalized cost saving for transfusions (RMB)	-	172.28	633.24

Transfusion cost assumes 800 RMB per unit red blood cell; TXA cost assumes 102.76RMB per 2 g; EACA cost assumes 235.72 RMB per 8 g
TXA tranexamic acid, EACA epsilon aminocaproic acid, RMB Renminbi
^*P < 0.05 for the comparison between EACA and control group
†P < 0.05 for the comparison between TXA and control group
^§P < 0.05 for the comparison between TXA and EACA group

ISSN: 1471-2474